Company profile: Societal CDMO
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services focused on small molecule therapies, including drug product formulation development; clinical and commercial manufacturing of solid and liquid products (including controlled substances and high-potency molecules); analytical development and QC testing; clinical trial packaging and labeling; and regulatory consulting and FDA submission support.
Products and services
- Commercial Finished Drug Product Manufacturing: Produces commercial-scale solid and liquid pharmaceuticals, accommodating controlled substances and high-potency molecules, with capabilities tailored to finished drug products
- Drug Product Formulation Development: Engineers small-molecule-focused formulations via pre-formulation assessment and design of oral solids, liquids, and injectables to create robust drug products
- Analytical Development and Quality Control Services: Delivers commercial-release QC testing and pre-formulation characterization, spanning analytical development from pre-formulation characterization through commercial QC release testing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Societal CDMO
Qualicaps
HQ: United States
Website
- Description: Provider of two-piece empty pharmaceutical capsules and processing equipment, including gelatin capsules for oral dosage forms and dry powder inhalers; plant-based hypromellose capsules suited to moisture-sensitive APIs; inhalation capsules with superior aerosolization; and capsule filling, band-sealing, and visual inspection machines for precision, integrity, and quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qualicaps company profile →
OctoPlus
HQ: The Netherlands
Website
- Description: Provider of specialty pharmaceutical expertise in the development of injectables. Based in a leading European bioscience park, the company is globally renowned and employs around 120 people representing over 20 nationalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OctoPlus company profile →
Tergus Pharma
HQ: United States
Website
- Description: Provider of end-to-end topical pharmaceutical research, drug development, testing, and manufacturing services as a CDMO, including contract R&D and commercial manufacturing for topical pharmaceuticals, plus cGMP-compliant testing services. Based in Durham, North Carolina.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tergus Pharma company profile →
Cellca
HQ: Germany
Website
- Description: Provider of upstream technologies and services for mammalian protein manufacturing, including a proprietary CHO expression platform, rapid cell line development (DNA to research cell bank in ~14 weeks), cGMP cell banking, cell line and product characterization, and cGMP lot release testing aligned with ICH and USP guidelines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellca company profile →
UAS Labs
HQ: United States
Website
- Description: Provider of science-backed probiotic solutions, offering documented strains for gut, immune, and women’s health; co-development of customized formulations, including those based on L. acidophilus DDS-1; and the STRAIN TO SOLUTION process ensuring stability and safety from development to final product. Also provides The Probiotics Institute educational platform and SCIENCE by Chr. Hansen strains supported by human clinical data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UAS Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Societal CDMO
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Societal CDMO
2.2 - Growth funds investing in similar companies to Societal CDMO
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Societal CDMO
4.2 - Public trading comparable groups for Societal CDMO
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →